Action HOOK HOOKIPA PHARMA INC.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues HOOKIPA Pharma Inc.

Actions

HOOK

US43906K1007

Marché Fermé - Nasdaq
Autres places de cotation
 22:00:00 15/05/2024 		Varia. 5j. Varia. 1 janv.
0,859 USD +4,15 % Graphique intraday de HOOKIPA Pharma Inc. +7,38 % +6,05 %
09/05 HOOKIPA Pharma Inc. annonce ses résultats pour le premier trimestre terminé le 31 mars 2024 CI
25/04 Transcript : HOOKIPA Pharma Inc. - Special Call

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
HOOKIPA Pharma Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
HOOKIPA Pharma Reports First Quarter 2024 Financial Results and Recent Business Highlights
HOOKIPA Pharma Announces Pivotal Phase 2/3 Trial Design for HB-200 in Combination with Pembrolizumab
HOOKIPA Pharma Inc. Announces Pivotal Phase 2/3 Trial Design for HB-200 in Combination with Pembrolizumab
HOOKIPA Pharma Announces FDA Clearance of its Investigational New Drug Application for HB-700 for the Treatment of KRAS-Mutated Cancers
HOOKIPA Pharma Inc. Announces FDA Clearance of Its Investigational New Drug Application for HB-700 for the Treatment of KRAS-Mutated Cancers
HOOKIPA Pharma Announces Grant of Inducement Award under Nasdaq Listing Rule 5635(4)
HOOKIPA Pharma Announces Grant of Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
HOOKIPA Pharma to Host Investor Call on HB-200 and Planned Path to Registration
HOOKIPA Pharma Inc. Announces European Medicines Agency Grant Prime Designation for the Investigational Product HB-200
HOOKIPA Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights
HOOKIPA Pharma Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
HOOKIPA Pharma Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
HOOKIPA Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights
North American Morning Briefing : Stocks Struggle After New Records
North American Morning Briefing : Stock Futures -2-
HOOKIPA Pharma to Participate in Leerink Partners Global Biopharma Conference
HOOKIPA Pharma to Cut 30% of Workforce in Restructuring
HOOKIPA Pharma Provides Update on Business Priorities and Oncology Partnership Programs
HOOKIPA Pharma Provides Update on Business Priorities and Oncology Partnership Programs
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action HOOK
  4. Actualités HOOKIPA Pharma Inc.
  5. Autres langues